Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2023-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jddst.2023.104753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer

  2023cited by this paper
• PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies

  2023cited by this paper
• siRNA-based nanocarriers for targeted drug delivery to control breast cancer

  2022cited by this paper
• Applications and challenges of ultra-small particle size nanoparticles in tumor therapy.

  2022cited by this paper
• Green biogenic silver nanoparticles, therapeutic uses, recent advances, risk assessment, challenges, and future perspectives

  2022cited by this paper
• Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis

  2022cited by this paper
• Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery- A review

  2022cited by this paper
• Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.

  2021cited by this paper
• Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management (Adv. Therap. 12/2021)

  2021cited by this paper
• Targeted Drug Delivery: Trends and Perspectives.

  2021cited by this paper
• Targeted and intracellular delivery of protein therapeutics by a boronated polymer for the treatment of bone tumors

  2021cited by this paper
• Breaking the vicious cycle between tumor cell proliferation and bone resorption by chloroquine-loaded and bone-targeted polydopamine nanoparticles

  2020cited by this paper
• Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.

  2020cited by this paper
• Locally Controlled Release of Methotrexate and Alendronate by Thermo-Sensitive Hydrogels for Synergistic Inhibition of Osteosarcoma Progression

  2020cited by this paper
• Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma

  2020cited by this paper
• Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.

  2020cited by this paper
• Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04

  2020cited by this paper
• RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies

  2020cited by this paper
• Tuning Ligand Density to Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.

  2020cited by this paper
• Engineering Biodegradable Multifunctional Antibacterial Bioactive Nanosystem for Enhancing Tumor Photothermo-Chemotherapy and Bone Regeneration.

  2019cited by this paper
• Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”

  2019cited by this paper
• Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery

  2019cited by this paper
• Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.

  2019cited by this paper
• Advances in personalized treatment of metastatic spine disease.

  2019cited by this paper
• Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer.

  2019cited by this paper
• Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis

  2019cited by this paper
• Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.

  2019cited by this paper
• Bone Metastasis: Current State of Play

  2019cited by this paper
• Carbon-Based Nanomaterials for Biomedical Applications: A Recent Study

  2019cited by this paper
• Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.

  2019cited by this paper
• A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co‐loaded liposomal formulation

  2019cited by this paper
• Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair.

  2019cited by this paper
• Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential

  2019cited by this paper
• Bone-Targeted Nanoplatform Combining Zoledronate and Photothermal Therapy To Treat Breast Cancer Bone Metastasis.

  2019cited by this paper
• Graphene oxide functionalized with chitosan based nanoparticles as a carrier of siRNA in regulating Bcl-2 expression on Saos-2 & MG-63 cancer cells and its inflammatory response on bone marrow derived cells from mice.

  2019cited by this paper
• A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors.

  2018cited by this paper
• pH-responsive mesoporous ZSM-5 zeolites/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma.

  2018cited by this paper
• Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cited by this paper
• Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.

  2018cited by this paper
• Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia.

  2018cited by this paper
• Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics

  2018cited by this paper
• Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR‐Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles

  2018cited by this paper
• Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer

  2018cited by this paper
• Bisphosphonate conjugation for bone specific drug targeting

  2018cited by this paper
• Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma.

  2018cited by this paper
• Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems

  2018cited by this paper
• Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect

  2018cited by this paper
• Mesoporous silica nanoparticles engineered for ultrasound-induced uptake by cancer cells.

  2018cited by this paper
• Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

  2018cited by this paper
• Foe to Friend: Supramolecular Nanomedicines Consisting of Natural Polyphenols and Bortezomib.

  2018cited by this paper
• Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy

  2018cited by this paper
• REGULATORY ROADMAP FOR NANOTECHNOLOGY BASED MEDICINES

  2018cited by this paper
• Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery

  2018cited by this paper
• Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review

  2018cited by this paper
• PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

  2018cited by this paper
• Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.

  2018cited by this paper
• A Carboxyl-Terminated Dendrimer Enables Osteolytic Lesion Targeting and Photothermal Ablation of Malignant Bone Tumors.

  2018cited by this paper
• Polymer–drug conjugate therapeutics: advances, insights and prospects

  2018cited by this paper
• Progress in the chemotherapeutic treatment of osteosarcoma.

  2018cited by this paper
• Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.

  2017cited by this paper
• Nanomedicine and epigenome. Possible health risks.

  2017cited by this paper
• Redox‐sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models

  2017cited by this paper
• Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

  2017cited by this paper
• Fabrication and Cytotoxicity of Gemcitabine-Functionalized Magnetite Nanoparticles

  2017cited by this paper
• Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy

  2017cited by this paper
• Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain

  2017cited by this paper
• Abstract LB-209: RON kinase: a target for treatment of cancer-induced bone destruction and osteoporosis

  2017cited by this paper
• Liposomal Formulations in Clinical Use: An Updated Review

  2017cited by this paper
• Improving radiotherapy in cancer treatment: Promises and challenges

  2017cited by this paper
• Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle.

  2017cited by this paper
• Advances in Micelle-based Drug Delivery: Cross-linked Systems.

  2017cited by this paper
• Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.

  2017cited by this paper
• Bisphosphonate‐functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer

  2017cited by this paper
• Engineered Multifunctional Nanomedicine for Simultaneous Stereotactic Chemotherapy and Inhibited Osteolysis in an Orthotopic Model of Bone Metastasis

  2017cited by this paper
• Triggering of apoptosis in osteosarcoma cells by graphene/single-walled carbon nanotube hybrids via the ROS-mediated mitochondrial pathway.

  2017cited by this paper
• Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer

  2017cited by this paper
• Injectable nanoengineered stimuli-responsive hydrogels for on-demand and localized therapeutic delivery.

  2017cited by this paper
• Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma.

  2017cited by this paper
• Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice.

  2017cited by this paper
• Challenges associated and approaches for successful translation of nanomedicines into commercial products.

  2017cited by this paper
• Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes.

  2016cited by this paper
• DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting

  2016cited by this paper
• Comparative study on in vivo response of porous calcium carbonate composite ceramic and biphasic calcium phosphate ceramic.

  2016cited by this paper
• Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management

  2016cited by this paper
• Bone metastasis: the importance of the neighbourhood

  2016cited by this paper
• Chemotherapy for Bone Sarcoma in Adults.

  2016cited by this paper
• Bone-Targeted Mesoporous Silica Nanocarrier Anchored by Zoledronate for Cancer Bone Metastasis.

  2016cited by this paper
• In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles.

  2016cited by this paper
• Biogenic terbium oxide nanoparticles as the vanguard against osteosarcoma.

  2016cited by this paper
• Synthesis and evaluation of alendronate-modified gelatin biopolymer as a novel osteotropic nanocarrier for gene therapy.

  2016cited by this paper
• Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.

  2016cited by this paper
• Review of Osteosarcoma and Current Management

  2016cited by this paper
• Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

  2016cited by this paper
• Canine Olfaction Science and Law : Advances in Forensic Science, Medicine, Conservation, and Environmental Remediation

  2016cited by this paper
• Tailoring the dendrimer core for efficient gene delivery.

  2016cited by this paper
• Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model

  2016cited by this paper
• Nanoparticles-Based Treatment for Bone Metastasis.

  2016cited by this paper
• Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis

  2016cited by this paper
• Co-delivery of drugs and plasmid DNA for cancer therapy.

  2016cited by this paper
• Gene delivery using calcium phosphate nanoparticles: Optimization of the transfection process and the effects of citrate and poly(l-lysine) as additives.

  2016cited by this paper

• Targeted Nanotechnology in Bone Cancer: Integrating Stimuli Responsive Drug Delivery and Artificial Intelligence for Personalized Therapy

  2026cites this paper
• Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study

  2025cites this paper
• A narrative review on the use of Green synthesized metallic nanoparticles for targeted cancer therapy.

  2025cites this paper
• Nanotechnology revolutionizing osteosarcoma treatment: Advances in targeted kinase inhibitors

  2025cites this paper
• Regulating nanomedicines: challenges, opportunities, and the path forward.

  2025cites this paper
• β-Lapachone NLCs — Repolarizing tumor-associated macrophages for osteosarcoma therapy

  2025cites this paper
• Current Advances in Nanocarriers for Cancer Therapy

  2025cites this paper
• From waste to value through sustainable synthesis of zinc oxide and nickel oxide Nanoparticles using Selenicereus undatus Peel extract: Anticancer activity against pancreatic Cancer cell line (PANC-1)

  2025cites this paper
• Nanoengineered chitosan functionalized titanium dioxide biohybrids for bacterial infections and cancer therapy

  2024cites this paper
• Synergistic anti-osteosarcoma cell effects of the methotrex-ate/PI3K/mTOR inhibitor nanoparticle codelivery system

  2024cites this paper
• A simple nanoplatform of thermo-sensitive liposomes and gold nanorods to treat bone metastasis through improved chemotherapy combined with photothermal therapy

  2024cites this paper
• Green synthesis of nickel oxide nanoparticles using leaf extract of Mimosa pudica for killing triple-negative breast cancer MDA-MB-231 cells and bacteria

  2024cites this paper
• Green engineering of NiO nanoparticles decorated with Arachis hypogaea shell extract for biomedical applications

  2024cites this paper
• Smart Nanocoating‐ an Innovative Solution to Create Intelligent Functionality on Surface

  2024cites this paper
• Cytotoxicity Enhancement in Osteosarcoma with Multifunctional I-131 Radiotherapeutic Nanoparticles: In Vitro Three-Dimensional Spheroid Model and Release Kinetics Modeling

  2024cites this paper